These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2139285)

  • 1. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P; Vranckx R; Meheus A
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].
    García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J
    Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients.
    Van Damme P; Vranckx R; Safary A; André FE; Meheus A
    Am J Med; 1989 Sep; 87(3A):26S-29S. PubMed ID: 2528294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against hepatitis B in preschool children with Down's syndrome.
    Vajro P; Lettera P; Fontanella A; Sbreglia C; Manzillo E; Sartorio R; Del Giudice E
    J Intellect Disabil Res; 1992 Feb; 36 ( Pt 1)():77-81. PubMed ID: 1533557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients.
    Bruguera M; Rodicio JL; Alcazar JM; Oliver A; Del Rio G; Esteban-Mur R
    Vaccine; 1990 Mar; 8 Suppl():S47-9; discussion S60-2. PubMed ID: 2139283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules.
    Scheiermann N; Gesemann M; Maurer C; Just M; Berger R
    Vaccine; 1990 Mar; 8 Suppl():S44-6; discussion S60-2. PubMed ID: 2139282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].
    García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI
    Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency.
    van Ditzhuijsen TJ; Kleijnen FM; Rijntjes PJ; van Loon AM; Yap SH
    Eur J Epidemiol; 1988 Sep; 4(3):349-56. PubMed ID: 2972557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines.
    Troisi CL; Heiberg DA; Hollinger FB
    JAMA; 1985 Dec; 254(22):3196-9. PubMed ID: 2933533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months.
    Goilav C; Prinsen H; Piot P
    Vaccine; 1990 Mar; 8 Suppl():S50-2; discussion S60-2. PubMed ID: 2139284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immunogenicity of the vaccine against the HBV in the mentally retarded].
    Cobo Soriano J; Gil Miguel A; Rey Calero J; Herrazo Cabrera R; Martín Hernández D
    Aten Primaria; 1991; 8(7):536, 538-40, 542. PubMed ID: 1836394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.
    Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Chitinand S; Sakulramrung R; Tannirundorn Y
    Vaccine; 1990 Mar; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: a two-year follow-up.
    Docci D; Cipolloni PA; Mengozzi S; Baldrati L; Capponcini C; Feletti C
    Nephron; 1992; 61(3):352-3. PubMed ID: 1386909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.